DSIP (delta sleep-inducing peptide)
Email me when the FDA rulemaking landsSafety
Editorial archive: these generated medical guides remain available only for review. This hub and its guides are not approved for indexing, AI citation, or treatment use.
SafetyDsip common mistakes people make with dosing and claimsThe most common DSIP mistakes: treating 1980s animal data as human proof, guessing at dosing, ignoring purity testing, and expecting nightly sleep effects.Read guide →SafetyDSIP overdose and toxicity: what the research actually showsNo published human LD50 or overdose case reports exist for DSIP. Here's what animal toxicity studies and self-injection risks actually show, and what's unknown.Read guide →SafetyDSIP withdrawal and stopping: what actually happensDoes stopping DSIP cause withdrawal or rebound insomnia? Here's what the thin human study record actually shows, and how people taper it in practice.Read guide →SafetyDSIP drug interactions: what's known, what isn'tNo formal human interaction studies exist for DSIP. Here's what the 1980s-90s research suggests about sedatives, opioids, and hormone drugs, and why caution matters.Read guide →SafetyDSIP long term side effects: what the research actually showsNo published human trial has tracked DSIP beyond a few weeks. Here's what the 1980s-90s studies found, and what's simply unknown about long-term use.Read guide →SafetyDSIP peptide side effects: what the research actually showsDSIP side effect data comes mostly from small 1980s-90s studies. Here's what was reported, what's unknown, and how it compares to other sleep peptides.Read guide →SafetyIs DSIP safe? What the human and animal data actually showDSIP's safety record comes from a handful of small, old trials and animal studies. Here's what's documented, what's missing, and what that means for you.Read guide →